Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 79.26B | -2.21%80.35B | -3.80%350.11B | -3.41%88.76B | -5.05%82.16B | 6.93%363.95B | 2.37%96.27B | -0.02%89.25B | 4.96%91.9B | 24.48%86.53B |
| Cost of revenue | 58.67B | -5.28%60.34B | 1.61%269.48B | 2.38%68.63B | 4.69%63.7B | 7.67%265.22B | 6.07%71.1B | 3.16%66.24B | 2.31%67.04B | 22.77%60.84B |
| Gross profit | 20.59B | 8.37%20.01B | -18.33%80.64B | -19.03%20.13B | -28.13%18.46B | 4.97%98.73B | -6.80%25.18B | -8.16%23B | 12.81%24.86B | 28.74%25.69B |
| Operating expense | 13.25B | -14.03%12.87B | 2.08%61.25B | 3.96%15.2B | 5.49%14.97B | 12.22%60B | 12.16%16.2B | 9.04%14.99B | 10.23%14.62B | 18.14%14.19B |
| Operating profit | 7.34B | 104.50%7.14B | -49.94%19.39B | -51.83%4.94B | -69.64%3.49B | -4.58%38.73B | -28.58%8.98B | -29.10%8.01B | 16.70%10.25B | 44.78%11.49B |
| Net non-operating interest income (expenses) | -187M | -358.82%-78M | -49.83%-451M | 34.52%-55M | -112.50%-17M | 30.80%-301M | -271.05%-141M | 23.60%-68M | 38.24%-84M | 95.35%-8M |
| Non-operating interest income | --361M | 30.99%465M | 19.78%1.51B | 18.93%333M | 2.90%355M | 108.24%1.26B | 34.44%324M | 103.23%315M | 143.48%280M | 259.38%345M |
| Non-operating interest expense | --548M | 45.97%543M | 25.56%1.97B | 6.59%388M | 5.38%372M | 50.19%1.57B | 66.67%465M | 56.97%383M | 45.02%364M | 31.72%353M |
| Net investment income | 509M | -140.86%-445M | -1.86%3.07B | -43.54%1.26B | 241.38%1.09B | 7.83%3.13B | 83.84%-327M | -41.94%911M | -12.69%2.22B | -60.52%319M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 4.13B | 192.31%38M | -88.12%43M | 0 | 1,200.00%13M | -15.42%362M | -0.53%372M | -236.00%-34M | -20.69%23M | 1M |
| Income from associates and other participating interests | 0 | 0 | 172.83%1.17B | 76.40%157M | 266.07%205M | 28.61%427M | 21.31%148M | 157.69%134M | -25.21%89M | 43.59%56M |
| Special income (charges) | -52M | -282.98%-86M | -242,396.55%-70.27B | -76.47%-30M | -72.67%47M | 103.46%29M | -416.67%-57M | 87.66%-69M | 92.44%-17M | 342.25%172M |
| Less:Restructuring and mergern&acquisition | ---61M | ---- | --1.47B | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Less:Other special charges | --113M | 282.98%86M | 2,393.10%665M | 76.47%30M | 72.67%-47M | -103.46%-29M | 416.67%57M | -87.66%69M | -92.44%17M | -342.25%-172M |
| Less:Write off | ---- | ---- | --68.13B | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -480M | -76.25%-141M | -57.18%-591M | -169.01%-460M | -42.86%-80M | 56.48%-376M | 64.34%-87M | 56.94%-62M | 35.96%-171M | 73.21%-56M |
| Income before tax | 11.26B | 35.33%6.42B | -213.45%-47.65B | -52.85%5.8B | -60.37%4.75B | -0.27%42B | -17.55%8.89B | -27.38%8.82B | 13.50%12.31B | 43.70%11.98B |
| Income tax | 2.68B | 11.98%2.49B | -59.95%5.3B | -22.79%2.76B | -29.00%2.22B | -10.41%13.24B | 25.53%4.15B | -40.13%2.39B | -18.04%3.57B | 0.22%3.13B |
| Net income | 8.58B | 55.88%3.94B | -284.14%-52.95B | -65.13%3.05B | -71.46%2.53B | 5.21%28.75B | -36.60%4.74B | -21.15%6.43B | 34.70%8.74B | 69.70%8.85B |
| Net income continuous operations | --8.58B | 55.86%3.94B | -284.14%-52.95B | -65.14%3.05B | -71.45%2.53B | 5.22%28.76B | -36.60%4.74B | -21.14%6.43B | 34.68%8.74B | 69.72%8.85B |
| Noncontrolling interests | 763M | 1.34%910M | 15.25%3.79B | 26.94%1.01B | 1.58%898M | -33.10%3.29B | -45.25%645M | -25.45%958M | -37.51%798M | -24.44%884M |
| Net income attributable to the company | 7.82B | 85.99%3.03B | -322.77%-56.74B | -74.38%2.03B | -79.57%1.63B | 13.61%25.47B | -35.00%4.09B | -20.34%5.47B | 52.43%7.94B | 96.93%7.96B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 7.82B | 85.99%3.03B | -322.77%-56.74B | -74.38%2.03B | -79.57%1.63B | 13.61%25.47B | -35.00%4.09B | -20.34%5.47B | 52.43%7.94B | 96.93%7.96B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 36.61 | 85.85%14.18 | -322.64%-265.94 | -74.38%9.54 | -79.58%7.63 | 13.59%119.45 | -35.04%19.19 | -20.34%25.66 | 52.37%37.24 | 96.94%37.36 |
| Diluted earnings per share | 36.6077 | 85.85%14.18 | -322.64%-265.94 | -74.39%9.5383 | -79.58%7.63 | 13.59%119.45 | -35.03%19.19 | -20.34%25.66 | 52.41%37.24 | 96.94%37.36 |
| Dividend per share | 0 | 0 | -16.67%30 | -16.67%15 | 0 | 20.00%36 | 20.00%18 | 0 | 20.00%18 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |